A. Naylor

发表

Novel C-2 substituted carbapenem derivatives. Part I. Synthesis and biological activity of non-aromatic heterocyclic derivatives.

M. J. Pearson, G. Burton, N. Clear, 1996, The Journal of antibiotics.

Evaluation of basic, heterocyclic ring systems as templates for use as potassium competitive acid blockers (pCABs).

E. Demont, A. Naylor, M. Bamford, 2009, Bioorganic & medicinal chemistry letters.

Chapter 9 – The role of medicinal chemistry in the drug discovery process

P. Beswick, A. Naylor, 2013 .

6-heteroaryl-pyrazolo[3,4-b]pyridines: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3).

A. Naylor, A. Takle, J. Witherington, 2003, Bioorganic & medicinal chemistry letters.

Pyridone derivatives as potent and selective VLA-4 integrin antagonists.

N. Parr, A. Naylor, A. Takle, 2006, Bioorganic & medicinal chemistry letters.

The identification of potent and selective imidazole-based inhibitors of B-Raf kinase.

David M. Wilson, A. Reith, F. King, 2006, Bioorganic & medicinal chemistry letters.

Aryl participation in methanolysis of N-chloro-1,4-dihydro-1,4-iminonaphthalenes (7-azabenzonorbornadienes) and derivatives

J. Malpass, A. Naylor, J. Davies, 1995 .

Synthetic approaches to nortropanes and nortrop-6-enes; intramolecular displacement by nitrogen in 7-membered rings

N. Howarth, J. Malpass, A. Naylor, 1993 .

15N nuclear magnetic resonance studies of azabicycles; unusual deshielding of nitrogen in the 7-azabicyclo[2.2.1]heptyl ring system

J. Malpass, A. Naylor, J. Davies, 1992 .

Synthetic Approaches to Nortropanes and Nortrop‐6‐enes; Intramolecular Displacement by Nitrogen in 7‐Membered Rings.

N. Howarth, J. Malpass, A. Naylor, 1993 .

15N NMR Studies of Azabicycles; Unusual Deshielding of Nitrogen in the 7-Azabicyclo(2.2.1)heptyl Ring System

J. Malpass, A. Naylor, J. Davies, 1993 .

Pyridone derivatives as potent, orally bioavailable VLA-4 integrin antagonists.

A. Naylor, A. Takle, J. Witherington, 2006, Bioorganic & medicinal chemistry letters.

The identification of potent, selective and CNS penetrant furan-based inhibitors of B-Raf kinase.

Robert P. Davis, David M. Wilson, A. Reith, 2008, Bioorganic & medicinal chemistry letters.

6-aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3).

A. Naylor, A. Takle, J. Witherington, 2003, Bioorganic & Medicinal Chemistry Letters.

Orally active C-6 heteroaryl- and heterocyclyl-substituted imidazo[1,2-a]pyridine acid pump antagonists (APAs).

E. Demont, A. Naylor, A. Takle, 2009, Bioorganic & medicinal chemistry letters.